Release Date: 13/09/22 08:49 Summary: High-grade results consolidate underground mining potential Price Sensitive: Yes Download Document 1.2MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%